Heritability of erythrocyte sodium permeability: A possible genetic marker for hypertension

Annals of Clinical and Laboratory Science

Volumn 39, Issue 3, 2009, Pages 241-250

  Lee, Jong Y ^a,b   Prineas, Ronald J ^a,b   Eaton, John W ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Blood pressure; Diuretics; Erythrocyte sodium permeability; Genetic linkage; Ion transport

Indexed keywords

FUROSEMIDE;

ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CELL MEMBRANE PERMEABILITY; CHILD PARENT RELATION; DIASTOLIC BLOOD PRESSURE; ERYTHROCYTE; FAMILY HISTORY; FEMALE; GENETIC MARKER; HERITABILITY; HUMAN; HUMAN CELL; HYPERTENSION; MALE; PRIORITY JOURNAL; SEGREGATION ANALYSIS; SODIUM TRANSPORT; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; BLOOD PRESSURE; CELL MEMBRANE PERMEABILITY; CHILD; DITHIOTHREITOL; ERYTHROCYTE MEMBRANE; FEMALE; FUROSEMIDE; GENETIC MARKERS; HUMANS; HYPERTENSION; MALE; PEDIGREE; SODIUM;

EID: 68949096692     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. DeMendoca M, Garay RP, Ben-Ishay D, Meyer P. Abnormal erythrocyte cation transport in primary hypertension: clinical and experimental studies. Hypertension 1981;3(Suppl 1):179-183. (Pubitemid 11013820)
2. Meneton PG, Warnock D. Involvement of renal apical Na transport systems in the control of blood pressure. Am J Kidney Diseases 2001;37(1 Suppl 2):S39-S47. (Pubitemid 32048022)
3. Baker EH. Ion channels and the control of blood pressure. Br J Clin Pharm 2000;49(3):185-198. (Pubitemid 30150979)
4. Cloix J-F, Devynck M-A, d'Herbigny E, Funck-Bretano JL, Meyer P. Electrophoretical characterization of red blood cell membrane proteins and plasma protein in spontaneously hypertensive rats. Biochem Biophys Res Comm 1982;105:1577-1581.
5. Okamoto K, Aoki K. Development of a strain of spontaneously hypertensive rats. Jap Circ J 1963;27:282-293.
6. + fluxes. Pflugers Arch 1983;399:74-78.
7. Yamori Y, Okamoto K. Zymogram analyses of various organs from spontaneously hypertensive rats. Lab Invest 1970;22:206-211.
8. Yamori Y, Horie R, Nara Y, Kihara M, Igawa T, Kanbe T, Mori K, Ikeda K. Genetic markers in spontaneously hypertensive rats. Clin Exp Hypertension 1981;3:713-725.
9. Bianchi G, Ferrari P. Animal models for arterial hypertension. In: Hypertension, 2nd ed (Genest J, Kuchel O, Hamet P, Cantin M, Eds), McGraw Hill, New York, 1983; pp 534-555.
10. Ferrari P, Barber BR, Torielli L, Ferrandi M, Salardi S, Bianchi G. The Milan hypertensive rats as a model for studying cation transport abnormality in genetic hypertension. Hypertension 1987;10(Suppl 1):I32-I36. (Pubitemid 18014167)
11. Trizio D, Ferrari P, Totielli L, Bianchi G. Expression at the hemopoietic stem cell level of the genetically determined erythrocyte membrane defects in the Milan hypertensive rat strain (MHS). J Hypertens 1983;1(Suppl 2):6-8. (Pubitemid 14186107)
12. Dahl LK, Heine M, Thompson K. Genetic influence of the kidneys on blood pressure: Evidence from chronic renal homograft in rats with opposite predisposition to hypertension. Cir Res 1974;34:94-101.
13. Williams RR, Hasstedt SJ, Hunt SC, Wu LL, Ash KO. Genetic studies of cation tests and hypertension. Hypertension 1987;10(Suppl 1):I37-I41.
14. Lee JY, Prineas RJ, Hallaway PE, Eaton JW. Determinants of natural variation in human erythrocyte sodium permeability. Am J Hematol 1987;26:27-36.
15. Lee JY. Assessment of ion transport, in Genetic Variation in Erythrocyte Membrane Ion Transport and Possible Relationship to Essential Hypertension (PhD thesis). University of Minnesota BioMedical Library, 1987, pp 56-98.
16. Mahoney JR, Etkin NL, McSwigan JD, Eaton JW. Assessment of red cell sodium transport in essential hypertension. Blood 1982;59:439-442.
17. Morton NE, Rao DC, Lalouel JM. Methods in genetic epidemiology. In: Contributions to Epidemiology and Biostatistics, vol 4 (Klingberg MA, Ed), Karger Press, Basel, 1983; pp 62-102.
18. Lalouel JM, Rao DC, Morton NE, Elston RC. A unified model for complex segregation analysis. Am J Hum Genet 1983;35:816-826.
19. Lalouel JM, Morton NE. Complex segregation analysis with pointers. Hum Hered 1981;31:312-321.
20. Feinleib M, Garrison RJ. The contribution of family studies to the partitioning population variation of blood pressure. Prog Clin Biol Res 1979;32:653-673.
21. Rona R, Beresford SA. The mode of inheritance of levels of blood pressure. J Epidemiol Comm Health 1980;34:168-173. (Pubitemid 10049462)
22. Biron P, Mongeau J, Bertrand J. Familial aggregation of blood pressure in adopted and natural children. In: Epidemiology and Control of Hypertension (Paul O, Ed), Grune Stratton, New York, 1975; pp 397-404.
23. Kesteloot H, Park BC, Lee CS, Brems-Heyns E, Claessens J, Joossens JV. A comparative study of blood pressure and sodium intake in Belgium and in Korea. Eur J Cardiol 1980;11:169-182. (Pubitemid 10119839)
24. Prineas RJ, Grimm R, Grandits G, Liebson P, Neaton J, Stamler J, Elmer P, Cutler J, Rautaharju P (the TOMHS Research Group). The effect of dietary sodium and body weight on echocardiographic measures of left ventricular mass among treated hypertensive men and women: four-year change in the TOMHS study. Nieren-und Hochdruckkrankheiten, Jahrgang 1994;23(I Suppl):S14-S21. (Pubitemid 24332082)
25. Korner A, Patak V, Dobos M, Madacsy L, Miltenyi M, Tulassay T. Reproducibility of erythrocyte sodiumlithium countertransport activity and ambulatory blood pressure measurements in type I diabetes mellitus, Acta Diabetologia 1998;35:104-108. (Pubitemid 28403242)
26. Petrov VV, Britov AN, Levitsky DO, Minchenko BI, Konstantinov EN, Svidersky VD, Novikov ID, Grishenkov EA, Lijnen PJ. Nonlinear relationship between erythrocyte sodium-lithium countertransport and blood pressure in man. Methods Findings Exp Clin Pharmacol 1994;16:661-666.
27. Adragna NC, Canessa ML, Solomon H, Slater E, Tosteson DC. Red cell lithium-sodium countertransport and sodium-potassium cotransport in patients with essential hypertension. Hypertension 1982;4:795-804. (Pubitemid 13176945)
28. Cooper R, LeGrady D, Nanas S, Trevisan M, Monsour M, Histand P, Ostrow D, Stamler J. Increased sodium-lithium countertransport in college students with elevated blood pressure. JAMA 1983;249:1030-1034. (Pubitemid 13137426)
29. Cusi D, Barlassina C, Ferrandi M, Lupi P, Ferrari P, Bianchi G. Familial aggregation of cation transport abnormalities and essential hypertension. Clin Exp Hypertension 1981;3:871-884. (Pubitemid 12163764)
30. Etkin NL, Mahoney JR, Forsthoefel MW, Eckman JR, McSwigan JD, Gillum RF, Eaton JW. Racial differences in hypertension-associated red cell sodium permeability. Nature 1982;297:588-589.
31. + cotransport function in a group of patients with essential hypertension. Eur J Clin Invest 1983;13:311-320.
32. Woods JW, Falk RJ, Pittman AW, Klemmer PJ, Watson BS, Namboodiri K. Increased red cell sodium-lithium countertransport in normotensive sons of hypertensive parents. NEJM 1982;306:593-595.
33. Glorioso N, Filigheddu F, Troffa C, Soro A, Parpaglia PP, Tsikoudakis A, Myers RH, Herrera VLM, Ruiz-Opazo N. Interaction of α1-Na,K-ATPase and Na,K,2Cl-cotransporter gene in human essential hypertension. Hypertension 2001;38:204-209. (Pubitemid 34224745)
34. Herrera VLM, Lopez LV, Ruiz-Opazo N. α1-Na,K-ATPase and Na,K,2Cl-cotransporter/D3 mit3 loci interact to increase susceptibility to salt-sensitive hypertension in Dahl SHSD rats. Mol Med 2001;7:125-134. (Pubitemid 33702028)
35. +-ATPase mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol 1996;269:C295-C311.
36. Rosati C, Meyer P, Garay R. Sodium transport kinetics in erythrocytes from spontaneously hypertensive rats. Hypertension 1988;11:41-48. (Pubitemid 18086309)
37. Gudbrandsson P, Herlitz H, Hansson L, Rydberg L. Human leukocyte antigens in patients with previous essential malignant hypertension. Clin Sci 1980;59:431s-434s.
38. Otero ML, Claros NM, Perez LL, Pinilla CF, Fernandez-Cruz A. Severe hypertension in the Spanish population. Association with specific HLA antigens. Hypertension 1983;5(Suppl V):V149-V152.
39. Patel R, Johnson J. Histocompatibility antigens in black patients with essential hypertension. Circulation 1981;64:1042-1044. (Pubitemid 11028104)
40. Sengar DPS, Couture RA, Jindal SL, Catching JD. Histocompatibility antigens in essential hypertension and myocardial infarction. Tissue Antigens 1985;8-171.
41. Heise ER, Moore MA, Reid QB, Goodman HO. Possible association of MN locus haplotypes with essential hypertension. Hypertension 1987;1:634-640.
42. Williams RR. A gene for high urinary kallikrein may protect against hypertension in Utah kindreds. Hypertension 1989;13:3-8.
43. Wong ZY, Stebbing M, Ellis JA, Lamantia A, Harrap SB. Genetic linkage of beta and gamma subunits of epithelial sodium channel to systolic blood pressure. Lancet 1999;353:2222-2225. (Pubitemid 29168460)
44. Rossier BC. 1996 Homer Smith Award Lecture. Cum grano salis: the epithelial sodium channel and the control of blood pressure. J Am S Nephrol 1997;8:980-992.
45. Hummier E, Rossier BC. Physiological and pathological role of the epithelial sodium channel in the control of blood pressure. Kidney Blood Pressure Res 1996;19:160-165.
46. Wong ZY, Stebbing M, Ellis JA, Lamantia A, Harrap SB. Genetic linkage of beta and gamma subunits of epithelial sodium channel to systolic blood pressure. Lancet 1999;353:2245-2246. (Pubitemid 29168460)
47. Melander O, Orho M, Fagerudd J, Bengtsson K, Groop I, Mattiasson I, Groop L, Hulthen UL. Mutations and variants of the epithelial sodium channel gene in Liddle's syndrome and primary hypertension. Hypertension 1998;31:1118-1124. (Pubitemid 28191506)
48. Garay RP, Dagher OG, Pernollet MG, Devynk MA, Meyer P. Inherited defect in a Na-K-cotransport system in erythrocytes from essential hypertensive patients. Nature 1980;284:281-283.
49. Canessa M, Bize I, Solomon H, Adragna N, Tosteson DC, Dagher G, Garay R, Meyer P. Na countertransport and cotransport in human red cells: function, dysfunction, and genes in essential hypertension, Clin Exp Hypertension 1981;3:783-795.
50. Trevisan M, Cooper R, Ostrow D, Miller W, Sparks S, Leonas Y, Allen A, Steinhauer M, Stamler J. Dietary sodium, erythrocyte sodium concentration, sodium-stimulated lithium efflux, and blood pressure. Clin Sci 1981;61:29S-32S. (Pubitemid 12177331)
51. Kupper N, Willensen G, Riese H, Posthuma D, Boomsma DI, de Geus EJ: Heritability of day time ambulatory blood pressure in an extended twin design. Hypertension 2005;45:80-85. (Pubitemid 40066418)
52. Fava C, Burri P, Almgren P, Groop L, Hulthen UL, Melander O. Heritability of ambulatory and office blood pressure phenotypes in Swedish families. J Hypertension 2004;22:1717-1721. (Pubitemid 39141963)
53. Quick I, Vonend O, Sellin L, Steghauer J, Dekomien G, Rump LC. A tale of two patients with Mendelian hypertension. Hypertension 2008;51:609-614. (Pubitemid 351301506)
54. Maslova MN, Titkov IS, Ogorodnikova LE. Na, K ATPase and pulmonary hemodynamics in the development of arterial hypertension. Kardiologila 1992;32:44-46.
55. Kolla V, Litwack G. Transcriptional regulation of the human Na/K ATPase via the human mineralocorticoid receptor. Mol Cell Biochem 2000;204:35-40. (Pubitemid 30111755)
56. +-ATPase activity in the central nervous system and endogenous sodium pump-inhibitor in the neural regulation of arterial blood pressure. J Cardiovasc Pharrmacol 1993;22:S13-S15.
57. +-ATPase for renal sodium reabsorption and its implications for hypertension. Hypertension 1996;27:219-227.
58. Blaustein MP, Zhang J, Chen L, Song H, Raina H, Kinsey SP, Izuka M, Iwamoto T, Kotlikoff MI, Lingrel JB, Philipson KD, Wier WG, Hamlyn JM. The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension. Hypertension 2009;53:291-298.
59. Piazza A. Who are the Europeans? Science 1993;260:9-11.
60. Malo D, Gros P, Bergmann A, Trask B, Mohrenweiser HW, Canfield VA, Levenson R. Genes encoding the H, K-ATPase α and Na, K-ATPase α3 subunits are linked on mouse chromosome 7 and human chromosome 19. Mammalian Genome 1993;4:644-649. (Pubitemid 2003418)
61. Aviv A, Lasker N. Proposed defects in membrane transport and intracellular ions as pathogenic factors in essential hypertension. In: Hypertension: Pathophysiology, Diagnosis and Management (Laragh JH, Brenner BM, Eds), Raven Press, New York, 1990; pp 923-937.
62. Hypertension Detection and Follow-up Program Cooperative Group. The hypertension detection and follow-up program: A progress report. Circ Res 1977;40(Suppl 1):106-109.
63. Preiss R, Prumke HJ, Sohr R, Muller E, Shmeck G, Schmidt J, Banaschak H. Sodium flux and lipid spectrum in the erythrocyte membrane in essential hypertension. Intern J Clin Pharm Ther Toxicol 1982;20:105-112. (Pubitemid 12191774)
64. 22Na in normotensive relatives of probands with established essential hypertension. Clin Sci 1979;57:321S-324S.
65. 22Na efflux and urinary sodium excretion in essential hypertension. Clin Sci 1980;59:195S-197S.
66. Canali M, Borghi E, Sani E, Curti A, Montranari A, Novarini A, Borchetti A. Increased lithium-sodium countertransport in essential hypertension: Its relationship to family history of hypertension. Clin Sci 1981;61:13S-15S. (Pubitemid 12177327)
67. Chun TY, Bankir L, Eckert GJ, Bichet DG, Saha C, Zaidi SA, Wagner MA, Pratt JH. Ethnic differences in renal responses to furosemide. Hypertension 2008;52:241-248.
68. Kalinowski L, Dobrucki IT, Malinski T. Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases. Circulation 2004;109:2511-2517. (Pubitemid 38720549)
69. Carson P, Ziesche S, Johnson G, Cohn JN. Racial differences in response to therapy for heart failure: analysis of the Vasodilator-Heart Failure Trials. J Cardiac Failure 1999;5:178-187. (Pubitemid 29449255)